CD274 and non-small cell lung carcinoma: Moreover, immunosuppression driven by purine metabolism in macrophages is linked to NLRP3/caspase-1/IL-1β signaling, whereas targeting this pathway could enhance antitumor immunity and the efficacy of anti-PD-L1 therapy in NSCLC [168].